Canadian Journal of Physiology and Pharmacology
LightNews LightNews
banner
physiolpharma.bsky.social
Canadian Journal of Physiology and Pharmacology
@physiolpharma.bsky.social
62 followers 83 following 92 posts
A @cdnsciencepub.com journal reporting current research in all aspects of physiology, nutrition, pharmacology, and toxicology.
Posts Replies Media Videos
Pinned
physiolpharma.bsky.social
Canadian Journal of Physiology and Pharmacology @physiolpharma.bsky.social · May 27
Looking for the right home for your research?

CJPP publishes high-quality work in all aspects of physiology, nutrition, pharmacology, and toxicology. Explore the scope and see if it’s the right fit for your next manuscript.

Publish with us ▶️ buff.ly/SwII29q
Social card promoting journal scope for the Canadian Journal of Physiology and Pharmacology.
physiolpharma.bsky.social
Looking for a way to make your next article #OpenAccess without adding to your research budget? University of Auckland | Waipapa Taumata Rau authors can publish in our journal with no APCs.

Details 📚▶️ https://ow.ly/YE0150XuWmz

#AcademicPublishing #UniversityOfAuckland #ScholarlyCommunication
Open Access Partnership logo featuring Canadian Science Publishing and University of Auckland on a red background.
December 18, 2025 at 11:10 PM
physiolpharma.bsky.social
What’s next for cardiovascular medicine? Explore the research from #IACSNAS2023 featured in this Canadian Journal of Physiology and Pharmacology collection for insight into how researchers are advancing the science of #HeartHealth.

🫀▶️ https://ow.ly/HnE850XqO0G
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
December 17, 2025 at 2:10 PM
physiolpharma.bsky.social
The Canadian Journal of Physiology and Pharmacology's updated scope highlights research on women’s health across the lifespan, with a focus on reproductive health, menopause, and gender-related diseases. Read more ▶️ https://ow.ly/2wWX50XwRIB
Close-up of a pregnant belly with hands gently resting on it, promoting research on women's health across reproductive and menopause stages.
December 16, 2025 at 2:35 PM
physiolpharma.bsky.social
Join the editorial team at the Canadian Journal of Physiology and Pharmacology! We’re seeking Associate Editors in fields like oncology, renal disease, or pharmacokinetics. Learn more ▶️ https://ow.ly/WphB50XqIzt

#AcademicPublishing #EditorialBoard #Pharmacology #Physiology
December 15, 2025 at 7:30 PM
physiolpharma.bsky.social
Aiming to make your research more discoverable? Monash University researchers can publish #OpenAccess with waived APCs in our journal 🔓▶️ https://ow.ly/IB9550XuRvQ

#ScholarlyPublishing #ScienceCommunication #AcademicPublishing
Open Access Partnership logo featuring Canadian Science Publishing and Monash University on a red background.
December 15, 2025 at 6:10 PM
physiolpharma.bsky.social
If you’re at the University of Arizona, you can publish #OpenAccess with us! This includes waived APCs and full read access to Canadian Science Publishing's portfolio. Learn more and publish with us 📚▶️ https://ow.ly/gVR250Xt2RH
Social card promoting Canadian Science Publishing's open access agreement with the University of Arizona.
December 15, 2025 at 1:45 PM
physiolpharma.bsky.social
We are inviting submissions for a collection on incretin hormones GLP-1 and GIP in cardiovascular disease! Research on cardiac metabolism, heart failure, and therapeutic strategies are welcome.

Submit before Nov. 1, 2026

Learn more 🫀▶️ https://ow.ly/8OnM50XrgCQ
3D transparent heart model highlighting kidneys with text about the Canadian Journal of Physiology and Pharmacology's call for papers: GLP-1, GIP, and heart incretin strategies in cardiovascular disease.
December 8, 2025 at 1:30 PM
physiolpharma.bsky.social
Want your work to reach a wider audience? Publish with us!

Researchers at the University of Melbourne can publish #OpenAccess in our journals with waived publishing fees. For more details 🔓▶️ https://ow.ly/RSJ650XuU5Z

#UniMelb #AcademicPublishing #ScholarlyPublishing #OpenScience
Open Access Partnership logo featuring Canadian Science Publishing and University of Melbourne on a red background.
December 8, 2025 at 12:45 PM
physiolpharma.bsky.social
Join our wonderful #PeerReview team! We’re looking for a Scientific Editor to help uphold rigorous peer review and support our editors, reviewers, and authors. Applications are now open.

Apply now 📚▶️ https://ow.ly/1ziL50XulU8

#ScienceJobs #NowHiring
Close-up of a fly resting on a green leaf with text announcing a Scientific Editor job opening at Canadian Science Publishing.
December 5, 2025 at 3:30 PM
physiolpharma.bsky.social
Take advantage of our #OpenAccess agreement with the University of Western Australia!

#UWA researchers can publish in our journal with waived APCs and have read access to our research. Details ▶️ https://ow.ly/l3Ex50XtNzM

#AcademicPublishing
Open Access Partnership logo featuring Canadian Science Publishing and University of Western Australia on a red background.
December 5, 2025 at 2:30 PM
physiolpharma.bsky.social
Seeking #OpenAccess pathways for your next paper? Researchers at the University of New South Wales have APC-free options and more with us!

🔓▶️ https://ow.ly/pGu750XuSPJ

#AcademicPublishing #UNSW #SciencePublishing
Open Access Partnership logo featuring Canadian Science Publishing and University of New South Wales on a red background.
December 4, 2025 at 6:45 PM
physiolpharma.bsky.social
Ready to bring your work to a global stage? 東京大学 The University of Tokyo / UTokyo authors can publish #OpenAccess in our journals without paying APCs. This agreement also provides full #ReadAccess to our research!

Publish with us 🤝▶️ https://ow.ly/8eT750XtJwn
Open Access Partnership logo featuring Canadian Science Publishing and University of Tokyo on a red background.
December 3, 2025 at 9:45 PM
physiolpharma.bsky.social
We now highlight research on cardiovascular, metabolic, and cancer-related disparities in underrepresented groups, including racial and ethnic minorities, LGBTQ+ populations, and communities with limited access to healthcare. Learn more ▶️ https://ow.ly/rOwK50XwScW

#CancerDisparities #HealthEquity
Close-up of a patient’s hand with an IV line, highlighting research on health disparities in cardiovascular, metabolic, and cancer conditions.
December 1, 2025 at 2:35 PM
physiolpharma.bsky.social
📰 Nampt: a new therapeutic target for modulating NAD+ levels in metabolic, cardiovascular, and neurodegenerative diseases

Read the full paper in this #IACSNAS2023 collection ▶️ https://ow.ly/YMbR50XqO7H

📸 cjpp-2024-0400_fig1 #CardiovascularResearch #HeartHealth
Effects of NAD+/NADH levels in disease pathophysiology and aging. An imbalance in the NAD+/NADH ratio generates reactive oxygen species, alters circadian rhythm, energy metabolism, inflammatory response and genome stability, and causes chronic metabolic diseases, cardiovascular and neurodegenerative diseases, aging, and cancer. NAD+, oxidized form of nicotinamide adenine dinucleotide; NADH, reduced form of nicotinamide adenine dinucleotide; ATP, adenosine triphosphate; and ROS, reactive oxygen species.
December 1, 2025 at 2:10 PM
physiolpharma.bsky.social
Calling all researchers, scholars, and SMEs who want to turn their ideas into impactful books!

Our publisher, Canadian Science Publishing, has partnered with UT Press Journals to launch a new science book publishing program. Find out more ▶️ https://ow.ly/fpjB50XoEzt
Collage of science book covers including titles on evolution, permafrost, parasites, and scientific careers with Canadian Science Publishing and University of Toronto Press logos.
November 28, 2025 at 8:30 PM
physiolpharma.bsky.social
The Canadian Journal of Physiology and Pharmacology publishes original research, reviews, perspectives, and more across physiology and pharmacology.

Publish with us 🍁▶️https://ow.ly/9fYT50XnmXC

#YourResearchHome
November 28, 2025 at 4:35 PM
physiolpharma.bsky.social
Women earn half of PhDs but face faculty underrepresentation. Memorial University, Newfoundland and Labrador took action. Four years later, women offered positions rose from 20% to 80%. Read more on our #CSPBlog 👩‍🔬▶️ https://ow.ly/iNgr50XmxbN

#EquityInAction #DiversityInSTEM
Two people exchanging a printed resume across a wooden table during a job interview setting indoors.
November 27, 2025 at 4:00 PM
physiolpharma.bsky.social
Hey attendees of #DiabetesCanada and #CSEM_SCEM conference. #CJPPjournal publishes your research on the effects of #IncretinTherapy on the #Heart. ❤️
See our #CallForPapers for our new GLP-1, GIP, and the Heart collection: https://ow.ly/tX1A50XylQL
#DiabetesAwarenessMonth
3D transparent human heart highlighting kidneys in red, promoting a call for papers on incretin-based cardiovascular disease strategies.
November 26, 2025 at 7:19 PM
physiolpharma.bsky.social
Our updated scope includes research on how nutrition, metabolism, and toxicology contribute to health outcomes that differ across gender and social determinants of health. Read more ▶️ https://ow.ly/iKQt50XwTcC

#NutritionScience #Metabolism #Toxicology
Close-up of fresh apples in crates with text about research on nutrition, metabolism, and toxicology in health outcomes.
November 26, 2025 at 2:35 PM
physiolpharma.bsky.social
Attention #UQResearchers!

The University of Queensland corresponding authors are eligible to publish #OpenAccess with no APCs in our journals and can benefit from full #ReadAccess to our portfolio. Details ▶️ https://ow.ly/UMBy50XtL6q

#OpenScience #AcademicSky
Open Access Partnership logo featuring Canadian Science Publishing and The University of Queensland on a red background.
November 26, 2025 at 12:30 PM
physiolpharma.bsky.social
We have a new scope! Key focus areas include cardiovascular, cell biology, metabolism, neuroscience, translational pharmacology, and clinical studies.

Read more ▶️ https://ow.ly/HX0R50Xw2SB

#Physiology #Pharmacology #NewScope
Hand holding two white pills with text about research on drug responses and pharmacokinetics in underrepresented groups.
November 24, 2025 at 2:10 PM
physiolpharma.bsky.social
📰 Epigenetic regulation by ketone bodies in cardiac diseases and repair

Read the full paper in this #IACSNAS2023 collection ▶️ https://ow.ly/lR5a50XqO3V
Sunset view of a bridge in Tampa illuminated with purple lights for the 10th Annual Meeting of IACS-NAS 2023.
November 24, 2025 at 2:10 PM
physiolpharma.bsky.social
We are inviting submissions for a collection on incretin hormones GLP-1 and GIP in cardiovascular disease! Research on cardiac metabolism, heart failure, and therapeutic strategies are welcome.

Submit before Nov. 1, 2026

Learn more 🫀▶️ https://ow.ly/8OnM50XrgCQ
3D transparent heart model highlighting kidneys with text about the Canadian Journal of Physiology and Pharmacology's call for papers: GLP-1, GIP, and heart incretin strategies in cardiovascular disease.
November 24, 2025 at 1:30 PM
physiolpharma.bsky.social
We're expanding our editorial board! We’re seeking clinician–researchers with expertise in #clinicalresearch to join as Associate Editors. Details ▶️ https://ow.ly/pvxM50XqIvR

#AcademicPublishing #PeerReview #Pharmacology #Physiology
Green imaging of organs.
November 18, 2025 at 7:30 PM
physiolpharma.bsky.social
Attended #ET19 this past September? Submit your research to our collection!

Publish with us ▶️https://ow.ly/7BUA50XrRXP
Suspension bridge at sunset with a call for papers for the Nineteenth International Conference on Endothelin by the Canadian Journal of Physiology and Pharmacology.
November 18, 2025 at 1:00 PM